- Previous Close
1,112.08 - Open
1,112.08 - Bid --
- Ask --
- Day's Range
1,112.08 - 1,112.08 - 52 Week Range
784.59 - 1,137.45 - Volume
1,008 - Avg. Volume
20 - Market Cap (intraday)
796.086B - Beta (5Y Monthly) 0.77
- PE Ratio (TTM)
45.04 - EPS (TTM)
24.69 - Earnings Date Nov 6, 2024
- Forward Dividend & Yield 13.08 (1.18%)
- Ex-Dividend Date Sep 3, 2024
- 1y Target Est
--
Corteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was incorporated in 2018 and is headquartered in Indianapolis, Indiana.
www.corteva.com22,500
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: CTVA.MX
View MorePerformance Overview: CTVA.MX
Trailing total returns as of 9/27/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CTVA.MX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CTVA.MX
View MoreValuation Measures
Market Cap
796.09B
Enterprise Value
850.37B
Trailing P/E
44.96
Forward P/E
16.92
PEG Ratio (5yr expected)
1.08
Price/Sales (ttm)
2.36
Price/Book (mrq)
1.56
Enterprise Value/Revenue
2.56
Enterprise Value/EBITDA
17.21
Financial Highlights
Profitability and Income Statement
Profit Margin
5.31%
Return on Assets (ttm)
2.89%
Return on Equity (ttm)
3.42%
Revenue (ttm)
16.9B
Net Income Avi to Common (ttm)
874M
Diluted EPS (ttm)
24.69
Balance Sheet and Cash Flow
Total Cash (mrq)
1.96B
Total Debt/Equity (mrq)
18.58%
Levered Free Cash Flow (ttm)
2.35B